HARROW, INC. — Director's Dealing 2016

Nov 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2016-11-02

Reporting Person: Kammer Robert J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-02	Common Stock	J	95000	$4.58	Acquired	1089827	Direct

Footnotes

F1: Dr. Kammer, as plaintiff, entered into a settlement agreement with a third party related to a lawsuit. As settlement consideration the third party paid Dr. Kammer 95,000 shares of the Company's common stock.